跳至主要内容
临床试验/NCT06109220
NCT06109220招募中不适用

Clinical Study on the Safety and Efficacy of Intrarticular Injection of Autologous Adipose-derived Vascular Matrix Components (SVF) in the Treatment of Knee Osteoarthritis (KOA)

Xijing Hospital1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年3月30日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
30
试验地点
1
主要终点
T2 mapping

研究概览

简要总结

The purpose of this study was to analyze and study the efficacy and safety of autologous adipose-derived vascular matrix components (SVF) in patients with knee osteoarthritis before and after treatment through clinical evaluation, radiation index, and metabolic index comparison between plasma and irrigation solution before and after SVF injection.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The age range is 20-70 years old
  • Patients with unilateral or bilateral knee degenerative inflammation (KOA) with Kellgren-lawrence rating of level 3 or lower
  • The physical health status is mainly in the ASA grade Ⅰ, Ⅱ and Ⅲ
  • Subjects had no active tumors, no active inflammation, no treponema pallidum, HIV, hepatitis B virus, or hepatitis C virus
  • The subject shall provide the physical examination report of knee X-ray examination, MRI examination and other items

排除标准

  • Patients with nonunion or displaced fractures around defective cartilage
  • Pregnant or lactating women
  • Autoimmune disease
  • Subjects with diabetes (exceptions are patients whose blood sugar levels remain within the normal range and diabetes has not caused other complications)
  • The patients had severe neurological diseases affecting the evaluation of postoperative results

结局指标

主要结局

T2 mapping

时间窗: 24 months after the first SVF injection into the knee cavity

The degree of change of articular cartilage was observed

次要结局

  • Western Ontario and McMaster Universities Arthritis Index (WOMAC)(24 months after the first SVF injection into the knee cavity)

研究者

发起方
Xijing Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验